Philipp A. Jaeger

Scientific Director at Boehringer Ingelheim

Vienna, Vienna, Austria

About

My passion is to integrate advanced biochemical, biophysical, and cellular assays into state-of-the-art drug discovery workflows. My strong background in systems biology, programming, and statistics enables me to lead a highly multidisciplinary team of researchers to detect biological relevance amongst the many hypotheses we test every day. As head of High-Throughput Biology here at BI, I have guided numerous projects from exploratory feeder stages to clinical candidate selection. During my career, I have co-authored multiple peer reviewed journal articles and book chapters, have written successful grant applications, and contributed to several patent applications. I have over 15 years of research and 7 years of start-up and industry experience and am well versed in leading successful teams of 25+ people in challenging and fast-paced environments. I thrive on accelerating R&D efforts and translating them into reliable discovery pipelines for pre-clinical and pre-production processes.

Experience

  • Boehringer Ingelheim (Full-time · 6 yrs 4 mos)
    • Scientific Director - Group Leader High-Throughput Biology
      May 2026 - Present · 2 mos

      • Leading a team of 25+ in High-Throughput Biology focused on early-stage drug discovery in Oncology. • Managing Biochemical, Biophysical, and Cellular Assay Labs to streamline assay development and deployment. • AI-Readiness: Assay Integration Lab, ensuring effective curation of internal and external data sources.

    • Team Lead (expat assignment)
      Nov 2025 - May 2026 · 7 mos

      • Leading four cellular assays labs as an interim team lead, ensuring seamless support for the entire TA portfolio. • Collaborating with cross-functional teams to enhance laboratory processes and operational efficiency. • Fostering a culture of innovation and teamwork, driving engagement and productivity among lab personnel and across sites.

    • Scientific Director - Group Head of High-Throughput Biology Vienna
      Jan 2021 - Nov 2025 · 4 yrs 11 mos

      Group Leader for High-Throughput Biology in Oncology, managing the Biochemical, Biophysical, and Cellular Assay Labs for early-stage drug discovery, as well as the Assay Integration Lab for curation of internal and external data sources.

  • Encodia, Inc. (Full-time · 1 yr 9 mos)
    • Senior Scientist, Assay Development
      Apr 2019 - Feb 2020 · 11 mos

      * High-throughput platform development for multi-cycle chemical and enzymatic reactions * Optimization of enzyme activities for peptide and oligo manipulation * Design of complex hybrid peptide-oligo architectures * Baselining, process & quality control, assay stabilization, multivariate data analysis * Core Team Lead

    • Scientist II, Assay Development
      Jun 2018 - Apr 2019 · 11 mos

      * Planning and implementation of robotics and automation solutions to enable scale-up * Optimization of bench-top assay biochemistry into a push-button-go high-throughput system

  • Scientist and Founder, Phenotype Screening and Drug Discovery at BiocipherX, Inc.
    Mar 2017 - Jun 2018 · 1 yr 4 mos

    * SBIR-funded start-up founder with patent, incubator, and pitching experience * High-throughput screening and drug discovery through small molecule characterization, phenotyping, and machine learning in a yeast model system

  • Postdoctoral Scholar, Systems Biology in Yeast and Humans - Ideker Lab at University of California San Diego
    Jul 2011 - Mar 2017 · 5 yrs 9 mos

    * Development of a phenotype screening platform for yeast genetic interaction screening * Model systems and bioinformatics tools for epigenetics and systems biology of aging and cancer * Plasma proteomic and integrative data analysis pipeline for Alzheimer's Disease and other dementias

  • PhD Student, Autophagy and Protein Signaling in Alzheimer's - Wyss-Coray Lab at Stanford University
    Jun 2006 - Jul 2011 · 5 yrs 2 mos

    * High-content plasma proteomics and biomarker discovery in neurodegenerative diseases * Antibody-based assay development for plasma proteomics in mice and humans * Molecular dissection of the role of Autophagy in Alzheimer's Disease